IU Simon Cancer Center taking high school and college applicants for its Summer Research Program

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

INDIANA UNIVERSITY MELVIN AND BREN SIMON CANCER CENTER is seeking high school and college applicants for its 2016 Summer Research Program.

The annual program, held in partnership with the Indiana University-Purdue University Indianapolis Center for Research and Learning, places students with a mentor physician or researcher for nine weeks. Students work with faculty who are conducting studies in cancer research.

The program’s primary goal is to increase the number of underrepresented populations engaged in basic, clinical and prevention and control cancer research by providing positive and meaningful first-hand exposure to those fields. Each student receives a stipend of $3,200 and is responsible for their own housing and transportation arrangements.

The program allows students to interact with any of the cancer center’s research programs, shared facilities and investigators; gain exposure to a wide range of basic science, translational and clinical research activities; and attend weekly career development workshops related to gaining admission to graduate and professional programs of study.

Students are selected based on interest in biomedical or behavioral science, academic performance and personal interviews. High school students who participate must have completed at least their junior year and have maintained a grade point average of at least 3.0 on a 4.0 scale. Undergraduates in the program must have completed 24 hours of college credit, be majoring in a biomedical or behavioral science, and have maintained a grade point average of at least 3.2.

The application deadline is Feb. 26, 2016. Those students selected as finalists will be invited to campus for an interview in April 2016.

Table of Contents

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login